General Information of the Compound
| Compound ID |
CP0403727
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[(3aR,9bS)-8-cyano-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-4-(4-aminophenyl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H30N4O2
|
||||||||||||||||||
| Molecular Weight |
466.585
|
||||||||||||||||||
| Canonical SMILES |
Nc1ccc(cc1)-c1ccc(cc1)C(=O)NCCCCN1C[C@@H]2COc3ccc(cc3[C@H]2C1)C#N
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H30N4O2/c30-16-20-3-12-28-26(15-20)27-18-33(17-24(27)19-35-28)14-2-1-13-32-29(34)23-6-4-21(5-7-23)22-8-10-25(31)11-9-22/h3-12,15,24,27H,1-2,13-14,17-19,31H2,(H,32,34)/t24-,27+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LLHCWQNGFVSDKL-SQHAQQRYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor